Actualmente, hay 15 estudios en reclutamiento

1 2
featured image
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Seve...

A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of 2 Active Dose Regimens of MORF-057 in Adults With...

Organización: Eli Lilly and Company

Sexo: ALL

Edades: 18 - 85 años

Enfermedades asociadas:

Enfermedad de Crohn activa. Adultos

featured image
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastati...

A Phase 2, Randomized, Active-controlled, Open-label, Multicenter Study of Belzutifan Plus Fulvestrant in Participants With Estrogen Receptor Positive...

Organización: Merck Sharp & Dohme LLC

Sexo: ALL

Edades: 18 - N/A años

Enfermedades asociadas:

Adultos Cáncer de mama

featured image
A Clinical Study of Molnupiravir to Prevent Severe Illness From Corona...

A Phase 3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitaliz...

Organización: Merck Sharp & Dohme LLC

Sexo: ALL

Edades: 18 - N/A años

Enfermedades asociadas:

Adultos COVID-19

featured image
Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Co...

A Randomized, Open-label, Phase 3 Study of MK-2870 vs. Platinum Doublets in Participants With EGFR-mutated, Advanced Nonsquamous Non-small Cell Lung C...

Organización: Merck Sharp & Dohme LLC

Sexo: ALL

Edades: 18 - N/A años

Enfermedades asociadas:

Cáncer de pulmón de células no pequeñas. Adultos

featured image
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac...

Phase 3 Study of Pembrolizumab in Combination With Carboplatin/Taxane (Paclitaxel or Nab-paclitaxel) Followed by Pembrolizumab With or Without Mainten...

Organización: Merck Sharp & Dohme LLC

Sexo: ALL

Edades: 18 - N/A años

Enfermedades asociadas:

Cáncer de pulmón de células no pequeñas. Adultos

featured image
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) ...

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Moderately to...

Organización: Merck Sharp & Dohme LLC

Sexo: ALL

Edades: 16 - 80 años

Enfermedades asociadas:

Enfermedad de Crohn activa. Adultos

featured image
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treat...

MK-5684-01A Substudy: A Phase 1/2 Umbrella Substudy of MK-5684-U01 Master Protocol to Evaluate the Safety and Efficacy of MK-5684-based Treatment Comb...

Organización: Merck Sharp & Dohme LLC

Sexo: ALL

Edades: 18 - N/A años

Enfermedades asociadas:

Cancer de prostata. Adultos

featured image
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Part...

A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pedia...

Organización: Merck Sharp & Dohme LLC

Sexo: ALL

Edades: 29 - 17 años

Enfermedades asociadas:

Cardiología pediátrica Falla cardíaca

featured image
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in P...

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Induction and Maintenance Study to Evaluate the Efficacy and Safety of PRA023 in Subjects Wit...

Organización: Merck Sharp & Dohme LLC

Sexo: ALL

Edades: 16 - 75 años

Enfermedades asociadas:

Colitis ulcerativa activa Gastroenterología adultos

1 2
Logo_CIC_web_medio

Contáctese con nosotros

+57 (2) 3319090 ext. 4022

"En FVL la investigación clínica se ha desarrollado enormemente y el CIC ha sido clave para organizarla, promoverla y fortalecer la formación de investigadores médicos"

Jorge Mejía

Cuidado Intensivo FVL

Centro de Investigaciones Clínicas, Fundación Valle del Lili. Cali – Colombia

Español / English